Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis ; volume:10 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-5 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (5.8.2024), 1-5, 12.2024
- Creator
-
Senkevich, Konstantin
Liu, Lang
Alvarado, Chelsea X.
Leonard, Hampton L.
Nalls, Mike A.
Gan-Or, Ziv
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00744-9
- URN
-
urn:nbn:de:101:1-2410252124295.663197951302
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Senkevich, Konstantin
- Liu, Lang
- Alvarado, Chelsea X.
- Leonard, Hampton L.
- Nalls, Mike A.
- Gan-Or, Ziv
- SpringerLink (Online service)
Other Objects (12)
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Cerebellar involvement in Parkinson’s disease resting tremor
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Cerebellar involvement in Parkinson’s disease resting tremor
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Cerebellar involvement in Parkinson’s disease resting tremor
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease